Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis (Q22299388)

2

Dhavalkumar D

Patel

1 reference

7 February 2023

T. Dryja

3

Thaddeus

Dryja

1 reference

7 February 2023

A. M. Wright

4

Andrew M

Wright

1 reference

7 February 2023

I. Koroleva

5

Irina

Koroleva

1 reference

7 February 2023

G. Bruin

6

Gerard

Bruin

1 reference

7 February 2023

C. Antoni

7

Christian

Antoni

1 reference

7 February 2023

Z. Draelos

8

Zoe

Draelos

1 reference

7 February 2023

M. H. Gold

9

Michael H

Gold

1 reference

7 February 2023

P. Durez

10

Patrick

Durez

1 reference

7 February 2023

P. P. Tak

11

Paul P

Tak

1 reference

7 February 2023

J. J. Gomez-Reino

12

Juan J

Gomez-Reino

1 reference

7 February 2023

C. S. Foster

13

C Stephen

Foster

1 reference

7 February 2023

R. Y. Kim

14

Rosa Y

Kim

1 reference

7 February 2023

C. M. Samson

15

C Michael

Samson

1 reference

7 February 2023

N. S. Falk

16

Naomi S

Falk

1 reference

7 February 2023

D. S. Chu

17

David S

Chu

1 reference

7 February 2023

D. Callanan

18

David

Callanan

1 reference

7 February 2023

Q. D. Nguyen

19

Quan Dong

Nguyen

1 reference

7 February 2023

A. Haider

21

Asifa

Haider

1 reference

7 February 2023

F. Di Padova

22

Franco

Di Padova

1 reference

7 February 2023

Kristine Rose

Kristine

Rose

Science Translational Medicine

20

1 reference

7 February 2023

language of work or name

English

0 references

publication date

6 October 2010

0 references

published in

0 references

volume

2

0 references

issue

52

0 references

page(s)

52ra72-52ra72

0 references

cites work

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

Structural basis of receptor sharing by interleukin 17 cytokines

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

Recent advances in the genetics of autoimmune disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001107

IL-17 family cytokines and the expanding diversity of effector T cell lineages

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Cutting edge: interleukin 17 signals through a heteromeric receptor complex

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Microbial lipopeptides induce the production of IL-17 in Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Mast cells express IL-17A in rheumatoid arthritis synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

TH-17 cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Type 17 T helper cells-origins, features and possible roles in rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

T(H)-17 cells in the circle of immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

The role of T cells in autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

The IL-23/Th17 axis in the immunopathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Psoriasis assessment tools in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

A quantitative definition of severe psoriasis for use in clinical trials

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Clinical outcome evaluation following cyclosporine a treatment in moderate to severe psoriasis: a retrospective study

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001107

7 January 2021

10.1126/SCITRANSLMED.3001107

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

519153

519153

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference